Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection

Department of Respiratory Virology, VP Chest Institute, University of Delhi, Delhi 110-007, India.
Experimental Lung Research (Impact Factor: 1.41). 07/2005; 31(5):449-59. DOI: 10.1080/019021490927088
Source: PubMed


In the mice, instillation of influenza virus A/Udorn/317/72(H3N2) intranasally resulted in a significant decrease in the pulmonary concentrations of catalase, reduced glutathione, and superoxide dismutase. There was a decrease in vitamin E level also. These effects were observed on the 5th day after viral instillation. Oral supplementation with quercetin simultaneous with viral instillation produced significant increases in the pulmonary concentrations of catalase, reduced glutathione, and superoxide dismutase. However, quercetin did not reverse the fall in vitamin E level associated with the viral infection. It is concluded that during influenza virus infection, there is "oxidative stress." Because quercetin restored the concentrations of many antioxidants, it is proposed that it may be useful as a drug in protecting the lung from the deleterious effects of oxygen derived free radicals released during influenza virus infection.

Download full-text


Available from: Pankaj Kumar, Sep 02, 2014
  • Source
    • "High mannose-binding lectins (HMBL) are powerful influenza and HIV inhibitors [154]. Rutin, quercetin, and related compounds, extracted from elderberry fruit (Sambucus nigra L.) [155] [156] [157] [158] [159] [160] [161] are other HA inhibitors. Xylopine and rosmaricin have an amine group that interacts with HA [162] [163]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the first part of this overview, we described the life cycle of the influenza virus and the pharmacological action of the currently available drugs. This second part provides an overview of the molecular mechanisms and targets of still-experimental drugs for the treatment and management of influenza. Briefly, we can distinguish between compounds with anti-influenza activity that target influenza virus proteins or genes, and molecules that target host components that are essential for viral replication and propagation. These latter compounds have been developed quite recently. Among the first group, we will focus especially on hemagglutinin, M2 channel and neuraminidase inhibitors. The second group of compounds may pave the way for personalized treatment and influenza management. Combination therapies are also discussed. In recent decades, few antiviral molecules against influenza virus infections have been available; this has conditioned their use during human and animal outbreaks. Indeed, during seasonal and pandemic outbreaks, antiviral drugs have usually been administered in mono-therapy and, sometimes, in an uncontrolled manner to farm animals. This has led to the emergence of viral strains displaying resistance, especially to compounds of the amantadane family. For this reason, it is particularly important to develop new antiviral drugs against influenza viruses. Indeed, although vaccination is the most powerful means of mitigating the effects of influenza epidemics , antiviral drugs can be very useful, particularly in delaying the spread of new pandemic viruses, thereby enabling manufacturers to prepare large quantities of pandemic vaccine. In addition, anti-viral drugs are particularly valuable in complicated cases of influenza , especially in hospitalized patients. To write this overview, we mined various databases, including Embase, PubChem, DrugBank and Chemical Abstracts Service, and patent repositories.
    Journal of preventive medicine and hygiene 12/2014; 55(4):109-129.
  • Source
    • "Docking studies have been performed using MOE 2008 . 10 . The crystal structure of HN protein ( PDB ID : 1USX ) was retrieved from Protein Data Bank ( http : / / www . rcsb . org / pdb / home / home . do ) ( Kumar et al . , 2005"
    [Show abstract] [Hide abstract]
    ABSTRACT: A series of novel substituted dihydropyrimidine and 5H-thiazolo [3, 2-a] pyrimidine derivatives were designed and synthesized as a potential target to discover drugs fighting against the viral diseases. The main objective of the present work is to carry out the QSAR studies for all the series of the compounds starting from 4a to 6j to find out their molecular descriptors and predict the biological properties. All of them are showing the best QSAR descriptors, hence chosen for the prediction of anti-viral activity against Newcastle disease virus (NDV). Initially their inhibitory activity was predicted by molecular docking of these compounds against haemaglutinin–neuraminidase (HN) protein using molecular operating environment (MOE) software. Based on the best affinity and highest docking scores 4b, 5b and 6b were assayed in vivo on NDV infected chicks and it was found that there is significant improvement in the survival of the chicks with the treatment (P < 0.05). 4b and 6b showed better curative effect than 5b at the dose concentration of 40 mg/kg body weight of chicks. The results from molecular docking study and biological assays can be inferred to consider these molecules as potential antiviral drugs.
    Antiviral Research 04/2012; Antiviral Research 95 (2012):118–127. · 3.94 Impact Factor
  • Source
    • "Thus, the enhancement of the body antioxidant defences through the diet or through a pharmacological treatment can be a proper approach in airways diseases. Among the natural antioxidants, such as glutathione, vitamins, beta-carotene, and selenium, great attention has been focused on flavonoids [15] [16], polyphenolic compounds largely present in fruits and vegetables, having anti-inflammatory, antibacterial activities and well-documented antioxidant effect. As a drawback, flavonoids show a poor bioavailability due to their susceptibility to oxidation, degradation in the gastric pH, very slight solubility in water and very low dissolution rate, leading to an irregular absorption from oral solid dosage forms [17]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present work was to develop dry powders containing naringin for a direct administration to the lung to combat oxidative stress. Naringin microparticles were prepared by spray-drying the neat flavonoid (2-5% w/v) from different water/ethanol co-solvents. The spray-dried powders were characterised for morphology, density, particle size distribution, residual humidity, crystallinity, solubility, thermal behaviour and respirable fraction. The fine fraction of the powders was measured by single-stage glass impinger and Andersen cascade impactor, using the Turbospin device for the deposition tests, wherein the dose to be aerosolised was premetered in a gelatine capsule. By increasing the ethanol content, the feed liquid turned from a suspension into a solution: the spray of flavonoid suspensions led to powders with high crystallinity degree, low water solubility and high bulk density, while the spray of drug solutions led to more amorphous particles, with higher solubility, lower density and improved aerodynamic behaviour. The optimisation of the operative parameters produced enhanced aerosol performance of the flavonoid powders containing only the active compound.
    European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 12/2008; 72(1):206-13. DOI:10.1016/j.ejpb.2008.10.007 · 3.38 Impact Factor
Show more